Moxibustion for Primary Dysmenorrhea

• Status: Completed
• Trial end date: 2014-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

Hypothesis: Moxibustion is effective for managing primary dysmenorrhea. Aim: To attest the effectiveness and safety of moxibustion for primary dysmenorrhea. Design: A randomized controlled trial. 152 participants will be included. Two arms: moxibustion treatment group and ibuprofen control group.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chengdu University of Traditional Chinese Medicine
• Treatments: Ibuprofen

Criteria

Inclusion Criteria:

• Clinical diagnosis of Guidelines of Primary dysmenorrhea clinical by the Society of Obstetricians and Gynaecologists of Canada

• Menstrual cycle is regular (28±7) days

• Syndrome differentiation of Traditional Chinese Medicine: Congealing cold-damp and Qi-stagnation and blood stasis

• Mean value of ≥40mm during last 3 months

• Informed consent form must be signed by patient or lineal relative

Exclusion Criteria:

• Patients with secondary dysmenorrhea, which is caused by endometriosis, pelvic inflammation, myoma of uterus and so on

• Patients who are unconscious and psychotic

• Patients with serious primary illness or diseases of cardiovascular, liver, renal, gastrointestinal, hematological systems and so on

• Patients take prostaglandin synthetase inhibitors (PGSI) 2 weeks before inclusion

• Pregnant women or women in lactation